O-GlcNAc transferase suppresses necroptosis and liver fibrosis

Worldwide, over a billion people suffer from chronic liver diseases, which often lead to fibrosis and then cirrhosis. Treatments for fibrosis remain experimental, in part because no unifying mechanism has been identified that initiates liver fibrosis. Necroptosis has been implicated in multiple live...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:JCI Insight
Päätekijät: Zhang, Bichen, Li, Min-Dian, Yin, Ruonan, Liu, Yuyang, Yang, Yunfan, Mitchell-Richards, Kisha A., Nam, Jin Hyun, Li, Rui, Wang, Li, Iwakiri, Yasuko, Chung, Dongjun, Robert, Marie E., Ehrlich, Barbara E., Bennett, Anton M., Yu, Jun, Nathanson, Michael H., Yang, Xiaoyong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Clinical Investigation 2019
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6948774/
https://ncbi.nlm.nih.gov/pubmed/31672932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.127709
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia